Pancreatic Cancer section

Prostate Cancer News & Features

Comparison of zoledronic acid dosing schedules finds less frequent schedule noninferior

Comparison of zoledronic acid dosing schedules finds less frequent schedule noninferior

ASCO 2015: 12-week dosing schedule of zoledronic acid is noninferior to a more-frequent schedule of every 4 weeks.

Researchers identify lynchpin molecule for prostate cancer metastasis

Researchers identify lynchpin molecule for prostate cancer metastasis

A single molecule appears to be the central regulator driving metastasis in prostate cancer.

Black men twice as likely to die from prostate cancer compared to white men

Black men twice as likely to die from prostate cancer compared to white men

Black men are twice as likely to be diagnosed with, or die from, prostate cancer in their lifetime compared to white men.

Research findings differentiate prostate cancer tumors into five different types

Research findings differentiate prostate cancer tumors into five different types

Prostate cancer has five distinct types, with different ways to determine which type of tumor a patient has.

Sensor technology can improve accuracy of prostate cancer diagnosis

Sensor technology can improve accuracy of prostate cancer diagnosis

A sensor chip, able to pick up on differences in glycoprotein molecules, can improve accuracy and efficiency of prostate cancer diagnosis.

Prostate Cancer Videos

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs